Barclays PLC Burning Rock Biotech LTD Transaction History

Barclays PLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	SELL	$0.91 - $2.29 $217,672 - $547,768	-239,200 Reduced 47.97%	259,407 $252,000
Q2 2023 Aug 03, 2023	SELL	$2.15 - $3.16 $234,300 - $344,367	-108,977 Reduced 17.94%	498,607 $1.07 Million
Q1 2023 May 04, 2023	SELL	$2.16 - $3.47 $1.1 Million - $1.77 Million	-509,309 Reduced 45.6%	607,584 $1.71 Million
Q4 2022 Feb 13, 2023	SELL	$1.73 - $2.95 $395,277 - $674,027	-228,484 Reduced 16.98%	1,116,893 $2.51 Million
Q3 2022 Nov 03, 2022	BUY	$2.39 - $3.96 $1.32 Million - $2.18 Million	550,925 Added 69.35%	1,345,377 $3.22 Million
Q2 2022 Aug 12, 2022	BUY	$1.75 - $10.44 $1.39 Million - $8.29 Million	794,452 New	794,452 $2.31 Million

21.2K

Ticker BNR
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 105,188,000
Market Cap $721M
Description
Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based cancer therapy selection and p...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.